Abstract:Background: The demonstrated role of mitogen-activated protein kinase (MAPK) in both cell apoptosis and the inflammation pathway makes it an attractive target for photoreceptor protection. The aim of this study was to investigate the protective effects of MAPK antagonists against photoreceptor degeneration and retinal inflammation in a rat model of light-induced retinal degeneration. Methods: Sprague Dawley rats were treated with intravitreal injections of MAPK antagonists, inhibitors of p-P38, phosphorylated-extracellular regulated kinase (p-ERK) 1/2, and p-c-Jun N-terminal kinase (JNK) just before they were assigned to dark adaptation. After dark adaptation for 24 h, rats were exposed to blue light (2500 lux) in a light box for 24 h, and then returned to the normal 12-h light/12-h dark cycle. Samples were collected at different time points. MAPK expression during light exposure was examined with immunofluorescence. Photoreceptor death was detected with histopathology and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The expression of retinal p-ERK1/2, caspase 3, activated caspase 3, tumor necrosis factor (TNF)-alpha, and interleukin (IL)-1 beta was examined by Western blotting. Differences between groups were evaluated using unpaired one-way analysis of variance and least significant difference post hoc tests. Results: MAPKs (P38, ERK1/2, and p-JNK) were phosphorylated and activated in the light injury groups, compared with normal group, and their expressions were mainly elevated in the outer nuclear layer (ONL). Among the selected MAPK antagonists, only the p-ERK1/2 inhibitor attenuated the loss of photoreceptors and the thinning of ONL in light injury groups. Besides, p-ERK1/2 inhibitor refrained light-induced photoreceptor apoptosis, which was presented by TUNEL positive cells. Light injury significantly increased the expression of p-ERK1/2 (1.12 +/- 0.06 vs. 0.57 +/- 0.08, t = 9.99, P < 0.05; 1.23 +/- 0.03 vs. 0.57 +/- 0.08, t = 11.90, P < 0.05; and 1.12 +/- 0.12 vs. 0.57 +/- 0.08, t = 9.86, P < 0.05; F = 49.55, P < 0.001), and induced caspase 3 activating (0.63 +/- 0.06 vs. 0.14 +/- 0.05, t = 13.67, P < 0.05; 0.74 +/- 0.05 vs. 0.14 +/- 0.05, t = 16.87, P < 0.05; and 0.80 +/- 0.05 vs. 0.14 +/- 0.05, t = 18.57, P < 0.05; F = 100.15, P < 0.001), compared with normal group. The p-ERK1/2 inhibitor significantly reduced p-ERK1/2 overexpression (0.61 +/- 0.06 vs. 1.12 +/- 0.06, t = -9.26, P < 0.05; 0.77 +/- 0.06 vs. 1.23 +/- 0.03, t = -8.29, P < 0.05; and 0.68 +/- 0.03 vs. 1.12 +/- 0.12, t = -7.83, P < 0.05; F = 49.55, P < 0.001) and downregulated caspase 3 activating (0.23 +/- 0.04 vs. 0.63 +/- 0.06, t = -11.24, P < 0.05; 0.43 +/- 0.03 vs. 0.74 +/- 0.05, t = -8.86, P < 0.05; and 0.58 +/- 0.03 vs. 0.80 +/- 0.05, t = -6.17, P < 0.05; F = 100.15, P < 0.001), compared with light injury group. No significant change in the total level of caspase 3 was seen in different groups (F = 0.56, P = 0.75). As for inflammation, light injury significantly increased the expression of TNF-alpha (0.42 +/- 0.04 vs. 0.25 +/- 0.05, t = 5.99, P < 0.05; 0.65 +/- 0.03 vs. 0.25 +/- 0.05, t = 14.87, P < 0.05; and 0.86 +/- 0.04 vs. 0.25 +/- 0.05, t = 22.58, P < 0.05; F = 160.27, P < 0.001) and IL-1 beta (0.24 +/- 0.01 vs. 0.19 +/- 0.02, t = 2.33, P < 0.05; 0.35 +/- 0.02 vs. 0.19 +/- 0.02, t = 7.97, P < 0.05; and 0.48 +/- 0.04 vs. 0.19 +/- 0.02, t = 14.69, P < 0.05; F = 77.29, P < 0.001), compared with normal group. P-ERK1/2 inhibitor significantly decreased the overexpression of TNF-alpha (0.22 +/- 0.02 vs. 0.42 +/- 0.04, t = -7.40, P < 0.05; 0.27 +/- 0.02 vs. 0.65 +/- 0.03, t = -14.27, P < 0.05; and 0.33 +/- 0.03 vs. 0.86 +/- 0.04, t = -19.58, P < 0.05; F = 160.27, P < 0.001) and IL-1 beta (0.13 +/- 0.03 vs. 0.24 +/- 0.01, t = -5.77, P < 0.05; 0.17 +/- 0.01 vs. 0.22 +/- 0.02, t = -9.18, P < 0.05; and 0.76 +/- 0.05 vs. 0.48 +/- 0.04, t = -13.12, P < 0.05; F = 77.29, P < 0.001), compared with light injury group. Conclusion: The p-ERK1/2 inhibitor might protect the retina from light-induced photoreceptor degeneration and retinal inflammation.

Antiapoptotic Role of the Cellular Repressor of E1A-stimulated Genes (CREG) in Retinal Photoreceptor Cells in a Rat Model of Light-Induced Retinal Injury.

CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway

Inhibiting the Activation of MAPK (ERK1/2) in Stressed Müller Cells Prevents Photoreceptor Degeneration

Effect of Phosphorylated-Extracellular Regulated Kinase 1/2 Inhibitor on Retina from Light-induced Photoreceptor Degeneration

Suppressing Autophagy Protects Photoreceptor Cells from Light-Induced Injury.

Elevation of P-Nr2as1232 by Cdk5/p35 Contributes to Retinal Ganglion Cell Apoptosis in a Rat Experimental Glaucoma Model

Light-Induced Lipocalin 2 Facilitates Cellular Apoptosis by Positively Regulating Reactive Oxygen Species/Bim Signaling in Retinal Degeneration

Inhibition of the MAPK/c-Jun-EGR1 Pathway Decreases Photoreceptor Cell Death in the rd1 Mouse Model for Inherited Retinal Degeneration

Neuroprotective effect of gene transfection of cyclic adenosine monophosphate response element binding protein on primary murine retinal ganglion cells

Inhibition of De Novo Ceramide Biosynthesis by FTY720 Protects Rat Retina from Light-Induced Degeneration

Suppressing endoplasmic reticulum stress-related autophagy attenuates retinal light injury

REG1A protects retinal photoreceptors from blue light damage

Activation of Autophagy and Paraptosis in Retinal Ganglion Cells after Retinal Ischemia and Reperfusion Injury in Rats

Repressing c-Jun N-terminal kinase signaling mitigates retinal pigment epithelium degeneration in mice with failure to clear all-trans-retinal

Enhanced Survival of Melanopsin-expressing Retinal Ganglion Cells after Injury is Associated with the PI3 K/Akt Pathway

Protection of Endogenous Erythropoietin on Photoreceptor Cells in Retinal Detachment and Its Mechanism

The Absence of C-Fos Prevents Light-Induced Apoptotic Cell Death of Photoreceptors in Retinal Degeneration in Vivo

PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury

Effect of Erythropoietin on Signal Transduction Pathway in Rat Model of Retinal Detachment

Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension.

Synthesized glucocorticoid-induced leucine zipper peptide (GILZ-P) inhibits photoreceptor apoptosis and protects retinal function in light-induced retinal degeneration model.